Advertisement

Topics

Zealand announces confirmatory Phase III results in hypoglycaemia

07:32 EDT 14 May 2019 | Pharmaceutical Technology

Copenhagen-based Zealand Pharma has announced positive results from a Phase III confirmatory study investigating dasiglucagon in patients with severe hypoglycaemia...
Read More...

The post Zealand announces confirmatory Phase III results in hypoglycaemia appeared first on Pharmaceutical Technology.

Original Article: Zealand announces confirmatory Phase III results in hypoglycaemia

NEXT ARTICLE

More From BioPortfolio on "Zealand announces confirmatory Phase III results in hypoglycaemia"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...